CD63 and melanoma: Furthermore, metastatic 4C11+ melanoma cells present decreased CD63 expression compared to non-metastatic 4C11-melanoma cells (Figure 2B), corroborating the data showing that inhibition of CD63 expression increased cell motility, matrix degrading activity and invasiveness of melanoma cells in vitro[42].